These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31909487)

  • 1. Custom dental trays with topical corticosteroids for management of gingival lesions of mucous membrane pemphigoid.
    Kulkarni R; Payne AS; Werth VP; Sollecito TP; Stoopler ET
    Int J Dermatol; 2020 Jun; 59(6):e211-e213. PubMed ID: 31909487
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical Occlusive Corticosteroid Therapy for the Treatment of Gingival Manifestation of Mucous Membrane Pemphigoid - a Case Report.
    Kavlakova L; Bachurska S
    Folia Med (Plovdiv); 2020 Dec; 62(4):866-870. PubMed ID: 33415936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucous membrane pemphigoid. Treatment experience at two institutions.
    Lamey PJ; Rees TD; Binnie WH; Rankin KV
    Oral Surg Oral Med Oral Pathol; 1992 Jul; 74(1):50-3. PubMed ID: 1508509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tacrolimus for oral cicatricial pemphigoid.
    Assmann T; Becker J; Ruzicka T; Megahed M
    Clin Exp Dermatol; 2004 Nov; 29(6):674-6. PubMed ID: 15550151
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays.
    Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Morales-Garcia P; Mesa-Aguado F; Bascones-Martinez A; Bravo M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):688-92. PubMed ID: 12789149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity.
    Scully C; Carrozzo M; Gandolfo S; Puiatti P; Monteil R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Jul; 88(1):56-68. PubMed ID: 10442946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-level laser therapy in the treatment of mucous membrane pemphigoid: a promising procedure.
    Yilmaz HG; Kusakci-Seker B; Bayindir H; Tözüm TF
    J Periodontol; 2010 Aug; 81(8):1226-30. PubMed ID: 20450370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic minocycline as a therapeutic option in predominantly oral mucous membrane pemphigoid: a cautionary report.
    Carrozzo M; Arduino P; Bertolusso G; Cozzani E; Parodi A
    Int J Oral Maxillofac Surg; 2009 Oct; 38(10):1071-6. PubMed ID: 19628373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of desquamative gingival lesions.
    Nisengard RJ; Rogers RS
    J Periodontol; 1987 Mar; 58(3):167-72. PubMed ID: 3470499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cicatricial pemphigoid: management in stomatology].
    Agbo-Godeau S; de Lima Soares P; Szpirglas H
    Rev Stomatol Chir Maxillofac; 2004 Sep; 105(4):206-10. PubMed ID: 15510070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone.
    Ciarrocca KN; Greenberg MS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Aug; 88(2):159-63. PubMed ID: 10468458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal disease series. Number III. Mucous membrane pemphigoid.
    Bagan J; Lo Muzio L; Scully C
    Oral Dis; 2005 Jul; 11(4):197-218. PubMed ID: 15984952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-BP180-type oral mucous membrane pemphigoid reactive to both NC16a and C-terminal domains.
    Uchiyama M; Mitsuhashi Y; Tsuboi R; Ishii N; Hayakawa T; Yasukochi A; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2015; 81(6):637-9. PubMed ID: 26515855
    [No Abstract]   [Full Text] [Related]  

  • 14. Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid).
    Chan LS
    Clin Dermatol; 2012; 30(1):34-7. PubMed ID: 22137224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucous membrane pemphigoid reactive only with BP230.
    Inoue T; Yagami A; Iwata Y; Ishii N; Hashimoto T; Matsunaga K
    J Dermatol; 2016 Oct; 43(10):1228-1229. PubMed ID: 27709732
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity.
    Carrozzo M; Cozzani E; Broccoletti R; Carbone M; Pentenero M; Arduino P; Parodi A; Gandolfo S
    J Periodontol; 2004 Oct; 75(10):1302-8. PubMed ID: 15562906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign mucous membrane pemphigoid with advanced periodontal involvement: diagnosis and therapy.
    Lilly JP; Spivey JD; Fotos PG
    J Periodontol; 1995 Aug; 66(8):737-41. PubMed ID: 7473017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of Koebner's phenomenon in the development of mucous membrane pemphigoid.
    Mostofi RS; Soltani K; Fine L
    J Prosthet Dent; 1986 May; 55(5):589-92. PubMed ID: 3519945
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral medicine case book 10. Gingival diseases.
    de Waal J; Dreyer WP
    SADJ; 2008 Aug; 63(7):406, 408. PubMed ID: 19054910
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral mucous membrane pemphigoid and pemphigus vulgaris-a retrospective two-center cohort study.
    Sultan AS; Villa A; Saavedra AP; Treister NS; Woo SB
    Oral Dis; 2017 May; 23(4):498-504. PubMed ID: 28084005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.